Trinity Capital Commits $45M In Growth Capital To Rapid Micro Biosystems For Automation In Healthcare Manufacturing

Trinity Capital Inc. (NASDAQ:TRIN) (the "Company"), a leading alternative asset manager, today announced the commitment of $45 million in growth capital to Rapid Micro Biosystems (NASDAQ:RPID) ("Rapid Micro"), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products.

Rapid Micro specializes in automating microbial quality control in mission-critical applications such as environmental monitoring, water testing, sterility testing, and bioburden testing. The Company's Growth Direct® platform provides faster results, greater accuracy, increased operational efficiency, and stronger data integrity, enabling customers to make quicker decisions that help ensure a safe and consistent supply of important healthcare products.